References
- Ahmed M, Ramadan W, Rambhu D, Shakeel F. (2008). Potential of nanoemulsions for intravenous delivery of rifampicin. Pharmazie, 63, 806–811.
- Baboota S, Shakeel F, Kohli K. (2006). Development and evaluation of once a day transdermal gel of diclofenacdiethylamine. Method Fin Exp Clin Pharmacol, 28, 109–114.
- Baboota S, Shakeel F, Ahuja A, Ali J, Shafiq S. (2007a). Design development and evaluation of novel nanoemulsion formulation for transdermal potential of celecoxib. Acta Pharm, 57,315–332.
- Baboota S, Alazaki A, Kohli K, Ali J, Dixit N, Shakeel F. (2007b). Development and evaluation of a microemulsion formulation for transdermal delivery of terbenafine. PDA J Pharm Sci Tech, 61, 276–285.
- Badawi AA, El-Laithy HM, El-Qidra RK, El-Mofty H, El-Dally M. (2008). Chitosan based nanocarriers for indomethacin ocular delivery. Arch Pharm Res, 31, 1040–1049.
- Hart F, Boardman P. (1963). Indomethacin: a new nonsteroidal anti-inflammatory agent. Br Med J, 5363, 965–970.
- Lawrence MJ, Rees GD. (2000). Microemulsion-based media as novel drug delivery systems. Adv Drug Deliv Rev, 45, 89–121.
- Nandi I, Bari M, Joshi H. (2003). Study of isopropyl myristate microemulsion systems containing cyclodextrins to improve the solubility of 2 hydrophobic drugs. AAPS Pharm Sci Tech, 4, E10.
- Shafiq S, Shakeel F. (2008). Enhanced stability of ramipril in nanoemulsion containing Cremophor-EL: a technical note. AAPS Pharm Sci Tech, 9, 1097–1101.
- Shafiq S, Shakeel F, Talegaonkar S, Ali J, Baboota S, Ahuja A, Khar RK, Ali M. (2007a). Formulation development and optimization using nanoemulsion technique: a technical note. AAPS Pharm Sci Tech, 8, E28.
- Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. (2007b). Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm, 66, 227–243.
- Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. (2007c). Design and development of ramipril nanoemulsion formulation: in vitro and in vivo assessment. J Biomed Nanotech, 3, 28–44.
- Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. (2007). Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS Pharm Sci Tech, 8, E104.
- Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. (2008a). Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment. J Drug Target, 16, 733–740.
- Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. (2008b). Skin permeation mechanism and bioavailability enhancement of celecoxib from transdermally applied nanoemulsion. J Nanobiotech, 6, E8.
- Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. (2008c). Skin permeation mechanism of aceclofenac using novel nanoemulsion formulation. Pharmazie, 63, 580–584.
- Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. (2008d). Accelerated stability testing of celecoxib nanoemulsion containing Cremophor-EL. African J Pharm Pharmacol, 2, 179–183.
- Shakeel F, Baboota S, Ahuja A, Ali J, Faisal S, Shafiq S. (2008e). Stability evaluation of celecoxib nanoemulsion containing Tween 80. Thai J Pharm Sci, 32, 4–9.
- Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. (2009a). Enhanced anti-inflammatory effects of celecoxib from a transdermally applied nanoemulsion. Pharmazie, 64, 258–259.
- Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. (2009b). Celecoxib nanoemulsion for transdermal drug delivery: characterization and in vitro evaluation. DOI: 10.1080/01932690802644012
- Trotta M. (1999). Influence of phase transformation on indomethacin release from microemulsions. J Control Release, 60, 399–405.
- Zabka M, Skoviera F. (2003). Microemulsions as vehicles for transdermal permeation of drugs. Acta Facult Pharm Univ Comenianae, 50, 147–155.